Abstract
Purpose
To conduct a prospective randomized study in order to investigate the effect of recombinant HCG (rHCG) on oocyte nuclear and cytoplasm maturity compared to urinary HCG (uHCG), for inducing ovulation in women treated with ICSI for male factor infertility.
Materials and Methods
We compared 89 patients randomly assigned to one of the two study groups. Group A consisted of 42 women who received a subcutaneous (s.c.) injection of 250 μg rHCG and group B consisted of 47 patients receiving an intramuscular (i.m.) injection of 10,000 IU uHCG.
Results
Patients treated with rHCG showed a rate of metaphase II oocytes, a number of metaphase II oocytes with mature cytoplasm and a rate of metaphase II oocytes with mature cytoplasm calculated from total MII oocytes statistically higher than in patients treated with uHCG. However this differences were not associated with a significantly better clinical outcome.
Conclusion
Our data show that in women treated with ICSI for male factor infertility, rHCG increases the rate of metaphase II oocytes, the number and the rate of MII oocytes with mature cytoplasm compared to uHCG. A larger study comparing transfer cycles of embryos all derived from oocytes with mature cytoplasm and transfer cycles of embryos all derived from oocytes with immature cytoplasm may be needed to clarify clinical correlations.
Similar content being viewed by others
References
Pierce JG, Parsons TF. Glycoprotein hormones: structure and function. Annu Rev Biochem. 1981;50:465–95. doi:10.1146/annurev.bi.50.070181.002341.
Zegers-Hochschild F, Fernandez E, Mackenna A, Fabres C, Altieri E, Lopez T. The empty follicle syndrome: a pharmaceutical industry syndrome. Hum Reprod. 1995;10:2262–5.
Chang P, Kenley S, Burns T, Denton G, Currie K, DeVane G, et al. Recombinant human chorionic gonadotropin (rhCG) in assisted reproductive technology: results of clinical trial comparing two doses of rhCG (Ovidrel) to urinary hCG (profasi) for induction of final follicular maturation on in vitro fertilization-embryo transfer. Fertil Steril. 2001;76:67–74. doi:10.1016/S0015-0282(01)01851-9.
Veeck LL. Atlas of the human oocyte and early conceptus. Baltimore: Williams and Wilkins; 1986.
Veeck LL. Oocyte assessment and biological performace. Ann N Y Acad Sci. 1988;541:259–74. doi:10.1111/j.1749-6632.1988.tb22263.x.
Veeck LL. Atlas of the human oocyte and early conceptus vol 2. Baltimore: Williams and Wilkins; 1991.
Fasolino A, Longo V, Capece G, Trotta R, Franco F, Fasolino MC. La valutazione della maturazione ovocitaria in pazienti sottoposte ad ICSI e trattate con r-FSH. Minerva Ginecol. 2001;53:157–63.
Bedford JM, Kim HH. Sperm/egg binding patterns and oocyte cytology in retrospettive analysis of fertilization failure in vitro. Hum Reprod. 1993;8:453–63.
Serhal PF, Ranieri DM, Kinis A, Marchant S, Davies M, Khadum IM. Oocyte morphology predicts outcome of intracytoplasmic sperm injection. Hum Reprod. 1997;12:1267–70. doi:10.1093/humrep/12.6.1267.
Palermo G, Joris H, Devroej P, Van Steirtegem AC. Pregnancies after intracytoplasmic injection of a single spermatozoon into an oocyte. Lancet. 1992;340:17–8. doi:10.1016/0140-6736(92)92425-F.
Van Steirteghem AC, Nagy Z, Joris H, Liu J, Staessen C, Smitz J, Wisanto A, Devroey P. High fertilization and implantation rates after intracytoplasmic sperm injection. Hum Reprod. 1993;8:1061–6.
Fishel S, Lisi F, Rinaldi L, Green S, Hunter A, Dowell K, Thornton S. Systematic examination of immobilizing spermatozoa before intracytoplasmic sperm injection in the human. Hum Reprod. 1995;10(3):497–500.
Ubaldi F, Rienzi L. Micromanipulation techniques in human infertilità: PZD, SUZI, ICSI, MESA, PESA, FNA and TESE. In Biotechnology of Human Reproduction. 2003. Parthenon Publisching. 315–336.
Veeck LL. Fertilization and early embryonic development. Curr Opin Obstet Gynecol. 1992;4(5):702–11. doi:10.1097/00001703-199210000-00010.
Polson DW, Mason HD, Saldahna MBY, Franks S. Ovulation of a single dominant follicle during treatment with low-dose pulsatile FSH in women with polycystic ovary syndrome. Clin Endocrinol (Oxf). 1987;26:205–12. doi:10.1111/j.1365-2265.1987.tb00778.x.
Albano C, Smitz J, Camus M, et al. Pregnancy and birth in an in vitro fertilization cycle after controlled ovarian stimulation in a woman with a history of allergic reactions to human menopausal gonadotrophin. Hum Reprod. 1996;11:1632–4.
Whitman-Elia GF, Banks K, O’Dea LS. Recombinant follicle stimulating hormone in a patient hypersensitive to urinary-derived gonadotrophins. Gynecol Endocrinol. 1998;12:209–12. doi:10.3109/09513599809015547.
Al-Inany HG, Aboughar M, Mansour R, Proctor M. Recombinant versus urinary human chorionic gonadotropin for ovulation induction in assisted conception. Cochrane Database Syst Rev. 2005;18(2):CD003719. Apr.
Discoll GL, Tyler JP, Hangan JT, Fisher PR, Birdsall MA, Kniight DC. A prospective, randomized, controlled, double-blind, double-dummy comparison of recombinant and urinary HCG for inducing oocyte maturation and follicular luteinization in ovarian stimulation. Hum Reprod. 2000;15:1305–10. doi:10.1093/humrep/15.6.1305.
Ludwig M, Doody KJ, Doody KM. Use of recombinant human chorionic gonadotropin in ovulation induction. Fertil Steril. 2003;79:1051–9. doi:10.1016/S0015-0282(03)00173-0.
European Recombinant Human Chroionic Gonadotrophin Study Group. Induction of final follicular maturation and early luteinization in women undergoing ovulation induction for assisted reproduction treatment-recombinant HCG versus urinary HCG. Hum Reprod. 2000;15:1446–51. doi:10.1093/humrep/15.7.1446.
Uhler ML, Beltsos AN, Grotjan HE, Lederer KJ, Lifchez AS. Age-matched comparison of recombinant and urinary HCG for final follicular maturation. Reprod Biomed Online. 2006;13(3):315–20.
Wehmann RE, Nisula BC. Characterization of a discrete degradation product of the human chorionic gonadotropin β-subunit in humans. J Clin Endocrinol Metab. 1980;51(1):101–5.
Penarrubia J, Balasch J, Fabregues F, et al. Recurrent empty follicle syndrome successfully treated with recombinant human chorionic gonadotrophin. Hum Reprod. 1999;14:1703–6. doi:10.1093/humrep/14.7.1703.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Farrag, A., Costantini, A., Manna, C. et al. Recombinant HCG for triggering ovulation increases the rate of mature oocytes in women treated for ICSI. J Assist Reprod Genet 25, 461–466 (2008). https://doi.org/10.1007/s10815-008-9262-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10815-008-9262-x